U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07041047) titled 'Evaluation of Apaisant Serum - Ingrown Nails for Ingrown Toenails' on March 17.
Brief Summary: To open-label clinical study aims to evaluate the efficacy and safety of APAISANT SERUM - INGROWN NAILS, a Class IIa CE-marked medical device, in relieving pain and discomfort associated with inflamed ingrown nails. The study includes 22 subjects with ingrown nails at stage 1 or 2, who will apply the product twice daily for 7 days. The primary objective is to assess the reduction of pain using a Numerical Rating Scale (NRS, 0-10). Secondary objectives include assessing discomfort, inflammation, and overall symptom improvement. The study al...